Guosen Innovation Equity
VC Fund
Guosen Innovation Equity is a VC fund focused on Therapeutics and Pharmaceutical. Guosen Innovation Equity operates as an equity investment and management platform.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 40%
Last updated:
For AI agents: llms.txt
Industries Guosen Innovation Equity invests in
Stages Guosen Innovation Equity invests in
Countries Guosen Innovation Equity invests in
Investment Focus
Industry
- Therapeutics 2 (40%)
- Pharmaceutical 2 (40%)
- Energy 1 (20%)
- Battery 1 (20%)
- Medical 1 (20%)
Stage
- Series B 3 (60%)
- Seed 1 (20%)
- Series A 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
ChengRui
|
ChengRui is a green energy integrated solution providing company. | Series B / May 27, 2025 | |
Curegene
|
Curegene focuses on the treatment of anti-viral diseases as well as cardiovascular and cerebrovascular diseases. The company has made strides in the development of small molecules and nucleic acid pharmaceuticals and currently possesses the most advanced targeted prodrug and nucleic acid drug technology platforms. | Series B / Oct 31, 2024 | |
Huize
|
Huize is a solid-state lithium-ion battery manufacturer and developer company.Huize is focused on the future of energy transformation, developing and manufacturing the next generation of solid-state lithium-ion batteries as well as providing system solutions. | Seed / Oct 21, 2024 | |
Ruining Bio
|
Ruining Bio provides clinical medical solutions such as tumor radiotherapy protection, wound repair, tumor embolization, and anti-tumor drugs. Ruining Bio brings together various professionals in materials, chemistry, biomedical engineering, and clinical medicine. | $8.5M / Series B / Jan 24, 2024 | |
HemaCell
|
Xueji Bio is a new cell therapy company founded by returnee experts to regenerate hematopoietic lineages (including blood cells and immune cells) in vitro, with unique stem cell reprogramming, editing and differentiation technologies. The company's unique iPSC establishment technology and gene targeting technology can quickly establish aplatform using platelet cells as a drug delivery carrier. | Series A / Dec 19, 2023 |
Co-Investors
Qiming Venture Partners
2 deals together
Aeonmed Medical Treatment
1 deal together
CDH Investments
1 deal together
Dingxin Capital
1 deal together
Hidden Hill Capital
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Guosen Innovation Equity invest in?
Guosen Innovation Equity invests primarily in Therapeutics, Pharmaceutical and Energy startups, most often at Series B and Seed stage. Most of the 5 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Guosen Innovation Equity last invest?
The most recent investment recorded for Guosen Innovation Equity closed in May 2025. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
